New Technology May Permit a Safer Approach to the Burgeoning Obesity and Type 2 Diabetes Problem

Reuters reports there are 2.1 Billion people suffering from obesity about the globe and obesity related disease costs exceeded $2 Trillion USD in 2015.  McKinsey who-obesity-angllosphereGlobal Institute forecasts the obesity market to reach $17 trillion USD by 2030 when half of the population is forecast to be obese. These obesity-related diseases include sleep apnea, gastric reflux, hypertension, autoimmune diseases and cancers, vascular disease, heart attacks and strokes, and most importantly type 2 diabetes.

The W.H.O. reports that the U.S. has the highest overweight and obesity proportion in the Anglosphere.  Over 2/3 of our population is overweight and 43% is forecast to be obese in a few years. 43% of blacks and Hispanics already are!  An individual’s lifetime costs of obesity are estimated at $92,235.   80% of type 2 diabetics are obese as obesity is the leading cause of type 2 diabetes.   Diabetes mellitus is the leading cause of renal failure needing dialysis, a frequent cause of blindness, and the most frequent indication for amputations. Obesity doesn’t just shorten your life, but it lessens its quality.

Read more

Recorded April 11 Traders Network Interview of BioSculpture Technology’s CEO Dr. Robert Cucin

CEO, Robert L. Cucin is interviewed by Michael Yorba on the I Heart Radio’s “Traders Network Show” on April 11, 2015.

Dr. Cucin discusses the rationale and potential of the endoscopic visceral lipectomy methods and devices the company is developing for the treatment of obesity, metabolic syndrome and type 2 diabetes.

Our patented technology will make it possible to remove fat WITHIN the belly safely.

BioSculpture Technology’s patented technology now makes it possible to safely and efficiently remove visceral or “belly” fat inside the abdomen for the first time.  This method has the potential of becoming a safer and highly effective alternative to current bariatric surgical treatments of obesity, metabolic syndrome and type 2 diabetes mellitus.

[youtube=http://youtu.be/ahK2YKypUTM]